| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |